Medullary Thyroid Cancer: Monitoring and Therapy
- 30 September 2007
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 36 (3) , 823-837
- https://doi.org/10.1016/j.ecl.2007.04.001
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Prognosis of medullary thyroid carcinomaCancer, 2006
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patientsEuropean Journal of Surgical Oncology, 2005
- Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patientsEuropean Journal of Surgical Oncology, 2005
- Impact of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients with Biochemical Evidence of Recurrent or Residual Medullary Thyroid CancerAnnals of Surgical Oncology, 2004
- RET and neuroendocrine tumorsCancer Letters, 2004
- Role of preoperative ultrasonography in the surgical management of patients with thyroid cancerSurgery, 2003
- Prognostic value of codon 918 (ATG?ACG)RET proto-oncogene mutations in sporadic medullary thyroid carcinomaInternational Journal of Cancer, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: Implications for therapyThe Journal of Pediatrics, 1996